High Throughput News and Research

RSS

Automation protocols for TruSeq kits is now available in Sciclone NGS Workstation

Caliper Life Sciences, today announced that it has developed and optimized automation protocols on its Sciclone NGS Workstation for Illumina's TruSeq DNA and TruSeq RNA sample preparation kits.

3 Feb 2011

First commercially available full length human MTOR protein with superior biological activity released

OriGene Technologies, Inc., a gene-centric life sciences company, releases the first commercially available full length human MTOR protein with superior biological activity.

2 Feb 2011

Agilent Technologies launches AssayMAP Bravo for protein purification

Agilent Technologies today announced the launch of the AssayMAP Bravo platform and protein purification cartridges, a fully automated solution for high-throughput protein sample preparation and purification.

1 Feb 2011

Agilent adds BenchBot Robot to line of automated microplate handling equipment

Agilent Technologies Inc. announced today the addition of the BenchBot Robot to its line of automated microplate handling equipment. As part of Agilent's Automation Solutions instrumentation portfolio, the BenchBot complements the Direct Drive Robot and BenchCel Microplate Handler.

1 Feb 2011

HighRes Biosolutions to build High-Throughput Laboratory Network for LANL-UCLA

A compact, self-contained, automated system for surveillance and screening of potential pandemic strains of influenza and other deadly infectious diseases is a step closer to reality, thanks to an agreement between Los Alamos National Laboratory, the University of California Los Angeles School of Public Health, and HighRes Biosolutions of Boston, Massachussets.

1 Feb 2011

St. Michael's Hospital to build first automated high-throughput zebrafish screening facility in Canada

Zebrafish are the new fruit flies.

27 Jan 2011

TD2 and Flagship Biosciences offer combined oncology and pathology services

TGen Drug Development (TD2) and Flagship Biosciences today announced a strategic alliance that should help speed new drugs safely into human testing and quickly benefit cancer patients.

27 Jan 2011

NuGEN, Caliper enter co-marketing agreement in next generation sequencing sample preparation methods

NuGEN Technologies, Inc. and Caliper Life Sciences, Inc. today announced a co-marketing agreement for the development of automated methods for next generation sequencing sample preparation on Caliper's Sciclone® NGS Workstation.

27 Jan 2011

Simple means of improving binding affinity of synbodies

Antibodies are watchdogs of human health, continuously prowling the body and registering minute changes associated with infection or disease with astonishing acuity. They also serve as biochemical memory banks, faithfully recording information about pathogens they encounter and efficiently storing this data for later use.

25 Jan 2011

University of California study may shed light on human ability to adapt hypoxia

In an important study that may shed light on human ability to adapt to hypoxia, or inadequate levels of oxygen, researchers at the University of California, San Diego School of Medicine have proven that the genome of flies exposed to long-term hypoxia are changed to permanently affect gene expression.

24 Jan 2011

Math may help assess how rapidly stem cells and cancer-causing cousins increase numbers

The difficult task of sorting and counting prized stem cells and their cancer-causing cousins has long frustrated scientists looking for new ways to help people who have progressive diseases.

21 Jan 2011

OMJPI, Sanford-Burnham enter agreement to discover compounds for Alzheimer's disease, psychiatric disorders

Sanford-Burnham Medical Research Institute has entered into a collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., to discover compounds for Alzheimer's disease and major psychiatric disorders.

18 Jan 2011

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."

14 Jan 2011

Exiqon launches 2nd generation of miRCURY LNA microRNA Inhibitor libraries for genome-wide screening

Exiqon A/S, a leading supplier of high-value gene expression analysis products, today announced the launch of the 2nd generation of miRCURY LNA microRNA Inhibitor libraries for genome-wide screening of microRNA function in human and mouse. Several libraries have already been shipped to the first customers.

12 Jan 2011

Study identifies over 30 breast cancer gene targets involved in drug resistance to chemotherapy

A new study conducted by Josh LaBaer's research team in the Biodesign Institute at Arizona State University has pinpointed more than 30 breast cancer gene targets ---including several novel genes---that are involved in drug resistance to a leading chemotherapy treatment.

11 Jan 2011

All fat cells not the same

All fat cells are not the same - a fact that has implications in the understanding and treatment of type 2 diabetes and obesity, said researchers from Baylor College of Medicine (www.bcm.edu) in a report that appears in the current issue of the Journal of Cell Biology (http://www.jcb.rupress.org/).

10 Jan 2011

Odyssey Thera granted U.S. Patent for high-throughput screening of proteins

Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays.

6 Jan 2011

VENENUM Biodesign relocates to new, state-of-the-art facility in Hamilton

VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify hits against its novel disease-based targets or its partners' targets, announced today its relocation to a brand-new, state-of-the-art facility in Hamilton, NJ in Mercer County.

5 Jan 2011

AMRI, Genentech enter research and licensing collaboration

AMRI announced today a research and licensing agreement with Genentech, a member of the Roche Group, for a family of antibacterial compounds discovered from AMRI's proprietary research of its natural products sample collection.

5 Jan 2011

Researchers develop microfluidic device to orient hundreds of embryos for research

Researchers have developed a microfluidic device that automatically orients hundreds of fruit fly and other embryos to prepare them for research. The device could facilitate the study of such issues as how organisms develop their complex structures from single cells -- one of the most fascinating aspects of biology.

27 Dec 2010

High Throughput News and Research

Automation protocols for TruSeq kits is now available in Sciclone NGS Workstation

First commercially available full length human MTOR protein with superior biological activity released

Agilent Technologies launches AssayMAP Bravo for protein purification

Agilent adds BenchBot Robot to line of automated microplate handling equipment

HighRes Biosolutions to build High-Throughput Laboratory Network for LANL-UCLA

St. Michael's Hospital to build first automated high-throughput zebrafish screening facility in Canada

TD2 and Flagship Biosciences offer combined oncology and pathology services

NuGEN, Caliper enter co-marketing agreement in next generation sequencing sample preparation methods

Simple means of improving binding affinity of synbodies

University of California study may shed light on human ability to adapt hypoxia

Math may help assess how rapidly stem cells and cancer-causing cousins increase numbers

OMJPI, Sanford-Burnham enter agreement to discover compounds for Alzheimer's disease, psychiatric disorders

IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB

Exiqon launches 2nd generation of miRCURY LNA microRNA Inhibitor libraries for genome-wide screening

Study identifies over 30 breast cancer gene targets involved in drug resistance to chemotherapy

All fat cells not the same

Odyssey Thera granted U.S. Patent for high-throughput screening of proteins

VENENUM Biodesign relocates to new, state-of-the-art facility in Hamilton

AMRI, Genentech enter research and licensing collaboration

Researchers develop microfluidic device to orient hundreds of embryos for research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News